Quest Diagnostics Incorporated
DGX
$178.03
-$0.81-0.45%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.82B | 2.76B | 2.65B | 2.62B | 2.49B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.82B | 2.76B | 2.65B | 2.62B | 2.49B |
| Cost of Revenue | 1.87B | 1.82B | 1.78B | 1.76B | 1.67B |
| Gross Profit | 951.00M | 944.00M | 869.00M | 866.00M | 816.00M |
| SG&A Expenses | 491.00M | 480.00M | 463.00M | 459.00M | 432.00M |
| Depreciation & Amortization | 39.00M | 39.00M | 39.00M | 37.00M | 32.00M |
| Other Operating Expenses | 1.00M | 2.00M | -1.00M | 2.00M | -1.00M |
| Total Operating Expenses | 2.40B | 2.34B | 2.28B | 2.25B | 2.14B |
| Operating Income | 420.00M | 423.00M | 368.00M | 368.00M | 353.00M |
| Income Before Tax | 336.00M | 393.00M | 294.00M | 304.00M | 302.00M |
| Income Tax Expenses | 77.00M | 97.00M | 59.00M | 68.00M | 65.00M |
| Earnings from Continuing Operations | 259.00M | 296.00M | 235.00M | 236.00M | 237.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -14.00M | -14.00M | -15.00M | -14.00M | -11.00M |
| Net Income | 245.00M | 282.00M | 220.00M | 222.00M | 226.00M |
| EBIT | 420.00M | 423.00M | 368.00M | 368.00M | 353.00M |
| EBITDA | 562.00M | 566.00M | 508.00M | 503.00M | 478.00M |
| EPS Basic | 2.17 | 2.51 | 1.97 | 1.98 | 2.01 |
| Normalized Basic EPS | 1.94 | 1.98 | 1.64 | 1.63 | 1.67 |
| EPS Diluted | 2.16 | 2.47 | 1.94 | 1.98 | 1.99 |
| Normalized Diluted EPS | 1.92 | 1.97 | 1.62 | 1.60 | 1.66 |
| Average Basic Shares Outstanding | 112.00M | 112.00M | 111.00M | 111.00M | 112.00M |
| Average Diluted Shares Outstanding | 113.00M | 113.00M | 113.00M | 113.00M | 113.00M |
| Dividend Per Share | 0.80 | 0.80 | 0.80 | 0.75 | 0.75 |
| Payout Ratio | 36.33% | 31.91% | 38.18% | 37.84% | 37.17% |